US Stock MarketDetailed Quotes

PTGX Protagonist Therapeutics

Watchlist
  • 44.490
  • -0.360-0.80%
Close Apr 25 16:00 ET
  • 44.030
  • -0.460-1.03%
Pre 05:56 ET
2.73BMarket Cap10.52P/E (TTM)

About Protagonist Therapeutics Company

Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943. The company was founded by Mark L. Smythe on August 22, 2006 and is headquartered in Newark, CA.

Company Profile

SymbolPTGX
Company NameProtagonist Therapeutics
Listing DateAug 11, 2016
Issue Price12.00
Founded2006
CEODr. Dinesh V. Patel, PhD
MarketNASDAQ
Employees126
Fiscal Year Ends12-31
Address7707 Gateway Boulevard,Suite 140
CityNewark
ProvinceCalifornia
CountryUnited States of America
Zip Code94560-1160
Phone1-510-474-0170
Websitehttp://www.protagonist-inc.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Dinesh V. Patel, PhD
  • Director, President and Chief Executive Officer
  • 7.07M
  • Dr. Arturo Molina, M.D.
  • Chief Medical Officer
  • --
  • Asif Ali
  • Executive Vice President, Principal Accounting Officer and Chief Financial Officer
  • 1.40M
  • Dr. Suneel Gupta, PhD
  • Executive Vice President, Clinical Development
  • 2.22M
  • Dr. Harold E. Selick, PhD
  • Chairman of the Board
  • 395.27K
  • Sarah A. O’Dowd
  • Independent Director
  • 341.52K
  • William D. Waddill
  • Independent Director
  • 364.02K
  • Bryan Giraudo
  • Independent Director
  • 356.52K
  • Dr. Lewis T. Willia M.D.,PhD
  • Independent Director
  • 351.52K

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Guangdong Hongjing Optoelectronic Technology Inc.
301479
+20.00%
Longkou Union Chemical
301209
+20.00%
Zhejiang Realsun Chemical
301212
+19.98%
4
NEW JCM GROUP
300157
+19.92%
5
Shenzhen S-king Intelligent Equipment
688328
+15.32%
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.